Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Anaissie: Infections in patients with chronic lymphocytic leukemia treated with fludarabine. (0.13 sec) 

Infections in patients with chronic lymphocytic leukemia treated with fludarabine

- annals.org
EJ Anaissie, DP Kontoyiannis, S O'Brien, H … - Annals of internal …, 1998 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Background: Fludarabine, a purine
analogue with activity in chronic lymphocytic leukemia, is usually well tolerated. Although ...
Cited by 223 - Related articles - BL Direct - All 3 versions

Infectious and immunosuppressive complications of purine analog therapy

- ascopubs.org [PDF] 
BD Cheson - Journal of Clinical Oncology, 1995 - jco.ascopubs.org
Purpose: The purine analogs fludarabine, cladribine, an- -pentostatin are active agents in the
treatment of in- dolent lymphoid malignancies. This report reviews the pattern, severity, and consequences
of the immunosup- pression and myelotoxicity associated with these agents. Methods: ...
Cited by 204 - Related articles - BL Direct - All 6 versions

The infectious complications of chronic lymphocytic leukemia


VA Morrison - Seminars in oncology, 1998 - 万方数据资源系统
Infectious complications continue to have a major impact on the clinical course of patients with
chronic lymphocytic leukemia despite advances in therapeutic approaches to this disease and
supportive care. Although the pathogenesis of infection in these patients is multifactorial, ...
Cited by 84 - Related articles - BL Direct - All 3 versions

Opportunistic pulmonary infections with fludarabine in previously treated patients …


JC Byrd, JB Hargis, KE Kester, DR … - American journal of …, 1995 - interscience.wiley.com
The high incidence of opportunistic pulmonary infections in fludarabine-treated patients at Walter
Reed Army Medical Center (WRAMC) and in the literature are described. A CancerLlt search
of fludarabine from June 1983-April 1994 with subsequent cross referencing and a ...
Cited by 86 - Related articles - BL Direct - All 4 versions

Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil …

- ascopubs.org
VA Morrison, KR Rai, BL Peterson, JE Kolitz, … - Journal of Clinical …, 2001 - jco.ascopubs.org
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... From the Veterans Affairs Medical
Center, Minneapolis, MN; Long Island Jewish Medical Center, New Hyde Park, and North ...
Cited by 80 - Related articles - BL Direct - All 8 versions

Infection and immunity in chronic lymphocytic leukemia.


S Tsiodras, G Samonis, MJ Keating, DP … - Mayo Clinic …, 2000 - mayoclinproc.highwire.org
Patients having chronic lymphocytic leukemia (CLL) are at increased risk for infectious morbidity
and mortality. The predisposition to infections in CLL patients has many components, including
both immunodeficiency related to the leukemia itself (humoral and cellular immune ...
Cited by 65 - Related articles - BL Direct - All 8 versions

Severe immunodeficiency in patients treated with fludarabine monophosphate


PW Wijermans, WBJ Gerrits, HL Haak … - European journal of …, 1993 - interscience.wiley.com
Abstract: Fludarabine monophosphate (FAMP) has been shown to be highly effective against
low-grade malignant B-cell lymphoproliferative diseases. Because some opportunistic infections
were observed in patients treated with FAMP, we investigated the influence of this drug ...
Cited by 125 - Related articles - BL Direct - All 4 versions

Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with …


S O'brien, H Kantarjian, M Beran, C Koller, M … - … : official journal of the …, 1997 - ncbi.nlm.nih.gov
The study was designed to determine whether administration of granulocyte colony-stimulating
factor (G-CSF) following fludarabine would reduce the incidences of myelosuppression and
infections. Twenty-five previously treated patients with Rai stage III-IV chronic lymphocytic ...
Cited by 51 - Related articles - BL Direct - All 2 versions

Clinical experience with fludarabine and its immunosuppressive effects in …


K Fenchel, L Bergmann, P Wijermans, A … - Leukemia & …, 1995 - informahealthcare.com
Leukemia cmd Lymphoma, Vol. 18, pp. 485-492 Reprints available directly from the publisher
Photocopying permitted by license only ... 0 1995 Harwood Academic Publishers GmbH Printed
in Singapore ... KLAUS FENCHEL,' LOTHAR BERGMA",' PIERRE WIJERMANS,* ...
Cited by 55 - Related articles - BL Direct - All 4 versions

Immunosuppressive effects and clinical response of fludarabine in refractory …


L Bergmann, K Fenchel, B Jahn, PS Mitrou, D … - Annals of …, 1993 - Eur Soc Med Oncology
Page 1. Annals of Oncology 4: 371-375. 1993. O 1993 Klmver Academic Publishers.
Printed in the Netherlands. Original article Immunosuppressive effects and clinical
response of fludarabine in refractory chronic lymphocytic leukemia ...
Cited by 73 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google